Eczema Cured

Cellceutix Corporation Selects Destum Partners To Partner Psoriasis Compound

Eczema / Psoriasis News From Medical News Today — Mon, 26 Jul 2010 12:00:00 +0000

Cellceutix Corporation (OTCBB: CTIX) is pleased to announce that it has selected Destum Partners to assist in finding a development partner for its psoriasis compound, KM-133. Cellceutix management has carefully evaluated which direction to take in the development of KM-133 and has concluded that this is the best way to create shareholder value...

Study Of Infections Associated With Eczema

Eczema / Psoriasis News From Medical News Today — Mon, 26 Jul 2010 07:00:00 +0000

The National Institute of Allergy and Infections Disease has awarded a five-year $31 million contract to National Jewish Health, which is leading a consortium of academic medical centers seeking to better understand skin infections associated with atopic dermatitis...

PsoriasisDX Genetic Test For Psoriatic Arthritis Now Available In Europe As A CE Marked In Vitro Diagnostic Medical Device

Eczema / Psoriasis News From Medical News Today — Thu, 22 Jul 2010 08:00:00 +0000

Molecular dermatology research and development innovator DermaGenoma, Inc. today announced that the PsoriasisDX Genetic Test for Psoriatic Arthritis (PsA) is now available as a CE Marked product under the European In Vitro Diagnostic Directive. CE Marking is required for certain product groups to indicate conformity with the essential requirements set out in European Directives...

Decrease In Pediatric Eczema Following Probiotic Use During Pregnancy And Breast Feeding

Eczema / Psoriasis News From Medical News Today — Thu, 22 Jul 2010 07:00:00 +0000

Mothers who drank milk with a probiotic supplement during and after pregnancy were able to cut the incidence of eczema in their children by almost half, a new study published in the British Journal of Dermatology has shown...

Occupational Asthma

MedicineNet Eczema Specialty — Wed, 23 Jun 2010 07:00:00 +0000

Title: Occupational Asthma
Category: Diseases and Conditions
Created: 6/23/2010 2:40:00 PM
Last Editorial Review: 6/23/2010 2:40:58 PM

NICE Final Draft Guidance Recommends Improved Access To Psoriatic Arthritis Treatments

Eczema / Psoriasis News From Medical News Today — Wed, 16 Jun 2010 20:00:00 +0000

Three treatments for psoriatic arthritis are recommended in final draft guidance published by the National Institute of Health and Clinical Excellence (NICE). Etanercept (Enbrel), infliximab (Remicade) and adalimumab (Humira) are proposed for treating adults with active and progressive psoriatic arthritis when specified criteria are met...

betamethasone dipropionate, Diprolene; Diprolene AF; (Diprosone, Alphatrex have been discontinued)

MedicineNet Eczema Specialty — Mon, 14 Jun 2010 07:00:00 +0000

Title: betamethasone dipropionate, Diprolene; Diprolene AF; (Diprosone, Alphatrex have been discontinued)
Category: Medications
Created: 12/31/1997
Last Editorial Review: 6/14/2010

Enbrel® (etanercept) Recommended In UK For Adults With Active And Progressive Psoriatic Arthritis By NICE

Eczema / Psoriasis News From Medical News Today — Mon, 14 Jun 2010 07:00:00 +0000

NICE (The National Institute for Health and Clinical Excellence) has recommended Enbrel® (etanercept) as a treatment option for adults with active and progressive psoriatic arthritis. NICE makes recommendations to the NHS (National Health Service) on new and existing medicines, treatments and procedures, and treating and caring for people with specific diseases and conditions...

Comment On Research Suggesting Early Introduction Of Fish Decreases The Risk Of Eczema In Infants

Eczema / Psoriasis News From Medical News Today — Fri, 11 Jun 2010 08:00:00 +0000

'There is now a wealth of research indicating that a person's diet can contribute to their risk of developing asthma and allergies, most likely as a result of their antioxidant, lipid and vitamin E intake...

Sunburn (Sun Poisoning)

MedicineNet Eczema Specialty — Fri, 11 Jun 2010 07:00:00 +0000

Title: Sunburn (Sun Poisoning)
Category: Diseases and Conditions
Created: 8/20/2008
Last Editorial Review: 6/11/2010